Home › Leucemia linfatica cronica › Colorado › Aurora
Studi clinici su Leucemia linfatica cronica a Aurora, CO
7 studi su Leucemia linfatica cronica cercano partecipanti presso sedi a Aurora e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
In reclutamentoFase 3
- Rocky Mountain Cancer Centers (Williams) Usor, Aurora
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
In reclutamentoFase 3
- Rocky Mountain Cancer Centers (Williams) Usor, Aurora
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
In reclutamentoFase 3
- Rocky Mountain Cancer Centers (Williams) Usor, Aurora
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
In reclutamentoFase 1/2
- Rocky Mountain Cancer Centers, Aurora
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
In reclutamentoFase 2
- Rocky Mountain Cancer Center, Aurora
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
In reclutamentoFase 3
- Rocky Mountain Cancer Centers - Aurora /ID# 267549, Aurora
Studi su Leucemia linfatica cronica in altre città
- Boston, MA31 studi
- Columbus, OH28 studi
- Durham, NC27 studi
- Washington, DC22 studi
- Seattle, WA20 studi
- Rochester, MN19 studi
- New York City, NY18 studi
- Houston, TX17 studi
- Baldwin Park, CA16 studi
- Milwaukee, WI15 studi
- Cincinnati, OH14 studi
- Chicago, IL14 studi
Altri studi a Aurora
- Cancro (tutti i tipi)35 studi
- Cancro colorettale32 studi
- Cancro del polmone non a piccole cellule30 studi
- Cancro al seno27 studi
- Cancro metastatico25 studi
- Cancro ovarico25 studi
- Diabete di tipo 123 studi
- Obesità21 studi
- Cancro ai polmoni19 studi
- Cancro alla prostata19 studi
- Insufficienza cardiaca18 studi
- Melanoma18 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.